DK200200624A - The polypeptide composition - Google Patents

The polypeptide composition Download PDF

Info

Publication number
DK200200624A
DK200200624A DK200200624A DKPA200200624A DK200200624A DK 200200624 A DK200200624 A DK 200200624A DK 200200624 A DK200200624 A DK 200200624A DK PA200200624 A DKPA200200624 A DK PA200200624A DK 200200624 A DK200200624 A DK 200200624A
Authority
DK
Denmark
Prior art keywords
polypeptide composition
polypeptide
composition
organic acid
amount
Prior art date
Application number
DK200200624A
Other languages
Danish (da)
Inventor
Shakhmatova Elena Lliinichna
Prutskova Nataliya Pavlovna
Uliyanova Mariya Viktorovna
Vanchugova Ljudmila Vitalievna
Staroseltseva L Konstantinovna
Knyazhev Vladimi Alexandrovich
Natochin Jury Viktorovich
Plate Nikolai Alfredovich
Valuev Lev Ivanovich
Sytov Gennady Alexeevich
Jay Henis
Original Assignee
Inst Neftechimicheskogo Sintez
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from RU99122655A external-priority patent/RU2171687C2/en
Application filed by Inst Neftechimicheskogo Sintez filed Critical Inst Neftechimicheskogo Sintez
Publication of DK200200624A publication Critical patent/DK200200624A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/28—Insulins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/27—Growth hormone [GH], i.e. somatotropin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/56—Protease inhibitors from plants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/55—Protease inhibitors
    • A61K38/57—Protease inhibitors from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Botany (AREA)
  • Diabetes (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Description

Patentkrav 1 Polypeptidsammensætning omfattende et polypeptid og en proteolytisk enzymhæmmer, kendetegnet ved, at den yderligere omfatter en organisk syre og et inaktivt excipiens med følgende forhold mellem bestanddelene (vægt-%)Patent claim 1 A polypeptide composition comprising a polypeptide and a proteolytic enzyme inhibitor, characterized in that it further comprises an organic acid and an inactive excipient having the following constituent ratios (wt%)

Polypeptid 1,0*95,0Polypeptide 1.0 * 95.0

Proteolytisk enzymhæmmer 0,02-10,0Proteolytic Enzyme Inhibitor 0.02-10.0

Organisk syre 1,0-94,0Organic acid 1.0-94.0

Inaktivt excipiens 0,2-98,8 (resten) 2 Sammensætning ifølge krav 1,kendetegnet ved, at den omfatter kendte forbindelser, der accelererer absorptionsprocessen, i en mængde, der er 10-50 gange større end mængden af polypeptidetInactive excipient 0.2-98.8 (residue) 2 Composition according to claim 1, characterized in that it comprises known compounds which accelerate the absorption process in an amount 10-1050 times greater than the amount of the polypeptide.

DK200200624A 1999-10-28 2002-04-25 The polypeptide composition DK200200624A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
RU99122655A RU2171687C2 (en) 1999-10-28 Polypeptide composition
PCT/RU2000/000427 WO2001030373A1 (en) 1999-10-28 2000-10-27 Polypeptide composition

Publications (1)

Publication Number Publication Date
DK200200624A true DK200200624A (en) 2002-06-21

Family

ID=20226315

Family Applications (1)

Application Number Title Priority Date Filing Date
DK200200624A DK200200624A (en) 1999-10-28 2002-04-25 The polypeptide composition

Country Status (6)

Country Link
AU (1) AU1316201A (en)
DE (1) DE10085144T1 (en)
DK (1) DK200200624A (en)
IL (1) IL149355A0 (en)
WO (1) WO2001030373A1 (en)
YU (1) YU31902A (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201701404D0 (en) 2017-01-27 2017-03-15 Micropharm Ltd Therapies for treating inflammatory disorders

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU225496B1 (en) * 1993-04-07 2007-01-29 Scios Inc Pharmaceutical compositions of prolonged delivery, containing peptides
RU2076733C1 (en) * 1994-03-23 1997-04-10 Институт нефтехимического синтеза им.А.В.Топчеева РАН Method of insulin derivatives preparing
FR2719479B1 (en) * 1994-05-04 1996-07-26 Sanofi Elf Stable lyophilized formulation comprising a protein: assay kit.
US5653987A (en) * 1995-05-16 1997-08-05 Modi; Pankaj Liquid formulations for proteinic pharmaceuticals
US5780431A (en) * 1996-09-20 1998-07-14 Neurobiological Technologies, Inc. Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form

Also Published As

Publication number Publication date
WO2001030373A8 (en) 2002-02-07
YU31902A (en) 2004-12-31
IL149355A0 (en) 2002-11-10
WO2001030373A1 (en) 2001-05-03
DE10085144T1 (en) 2003-04-24
AU1316201A (en) 2001-05-08

Similar Documents

Publication Publication Date Title
BG103392A (en) Serine protease inhibitors, in particular of hepatitis with virus ns3 protease
MY122621A (en) Compositions containing a high percent saturation concentration of antibacterial agent
ATE227082T1 (en) SYNERGISTIC BIOCIDE COMPOSITION
NO996053D0 (en) Perfumed one- and two-phase compositions to reduce body odor, as well as the method of use thereof
PT1061955E (en) POLYNUCLEOTIDE COMPOSITION, PREPARATION METHOD AND ITS USE
MA25820A1 (en) COMBINATIONS OF DIPEPTIDYL PEPTIDASE IV INHIBITORS AND OTHER ANTIDIABETIC AGENTS FOR THE TREATMENT OF DIABETES MELLITUS.
MY140680A (en) Hepatitis c virus inhibitors
ATE334666T1 (en) NEW FATTY ACID ANALOGUES FOR THE TREATMENT OF FATTY LIVER
DE69928006D1 (en) STABILITY LIQUID COMPOSITIONS OF GLUCAGON-SIMILAR PEPTIDE-1
DK0690049T3 (en) Agent for the treatment of hepatobiliary diseases
BR9811099A (en) Urokinase inhibitors
NO20000265D0 (en) Controlled cytolysis of target cells, agents and compositions that cause cytolysis and compounds that can be used to prepare the agents
IL140159A0 (en) Neuroprotective composition for the prevention and/or treatment of nervous and behavioral alterations due to anxiety states or depression
ES2173903T3 (en) COMPOSITIONS THAT INCLUDE PENTAFLUOROBUTAN AND ITS USE.
UA50808C2 (en) Composition for treatment of irds and ards
WO2002005642A3 (en) Synergistic biocidal compositions
MX9603221A (en) Limescale removing compositions.
MXPA03006455A (en) Improvements in or relating to liquid detergent compositions.
DK200200624A (en) The polypeptide composition
ATE239779T1 (en) BLEACHING AGENT COMPOSITIONS
DK0705112T3 (en) Compositions for deodorizing animal excrement and associated deodorization methods
EP1555033A3 (en) Polynucleotide composition, method of preparation, and use thereof
NO854009L (en) FERTILIZATION PREVENTING SYNERGISTIC EFFECT.
IT1274483B (en) PHARMACEUTICAL COMPOSITIONS CONTAINING GEMFIBROZIL
PL335167A1 (en) Fungicidal compositions and method of reducing

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment